Arcus Biosciences, Inc. (RCUS) Operating income 2016–2025
Arcus Biosciences, Inc. (RCUS) annual operating income history from SEC filings — each fiscal year as reported.
-$386.0MFY2025 · since FY2016: -$18.2M → -$386.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$386.0M | -17.0% |
| FY2024 | -$330.0M | +2.9% |
| FY2023 | -$340.0M | -21.4% |
| FY2022 | -$280.0M | -618.5% |
| FY2021 | $54.0M | +143.5% |
| FY2020 | -$124.0M | -39.8% |
| FY2019 | -$88.7M | -61.7% |
| FY2018 | -$54.9M | -2.7% |
| FY2017 | -$53.4M | -193.9% |
| FY2016 | -$18.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice